tradingkey.logo
tradingkey.logo
Search

Inhibikase Therapeutics Inc

IKT
Add to Watchlist
1.520USD
-0.010-0.65%
Close 11-13 16:00(ET)
212.10MMarket Cap
LossP/E TTM

Today

-0.65%

5 Days

+1.33%

1 Month

-16.94%

6 Months

-12.14%

Year to Date

-25.85%

1 Year

-0.65%

Key Figures

1.560Open
1.590High
40.98KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
1.530Prev. Close
1.485Low
61.74KTurnover
LossP/E Static
1.38P/B
0.00%Div Yield TTM
-38.09%ROA
2.61052wk High
0.08Volume Ratio
-27.52MNet Profit
139.54MShares
-0.4332EPS TTM
0.94Beta
-40.23%ROE
1.40052wk Low
6.86%Amplitude
100.00%Gross Margin
212.10MMarket Cap
2.10Reward/Risk
4.03%Risk Rate
More news coming soon, stay tuned...

Inhibikase Therapeutics Inc's Score

-0.05vs previous score
Forecast8.60
Financial Health6.59
Technical4.05
Valuation Dimensions6.61
Institutional Confidence7.00
Risk Assessment3.41

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
5.550Target Price
+258.06%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy44432232
Buy55555555
Hold11000000
Sell00000000
Strong Sell00000000

Inhibikase Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
--/-0.11
Revenue / Forecast
--/0.00

Inhibikase Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolIKT
Number of employees15
CountryUnited States of America

Ownership

ShareholdersProportion
Sands Capital Ventures LLC9.86%
Soleus Capital Management, L.P.8.24%
Fairmount Funds Management LLC6.53%
Adar1 Capital Management LLC6.11%
Shareholder TypesProportion
Hedge Fund43.67%
Investment Advisor20.91%
Investment Advisor/Hedge Fund9.78%
Corporation4.42%

FAQs

What is the current price of Inhibikase Therapeutics Inc (IKT)?

The current price of Inhibikase Therapeutics Inc (IKT) is 1.52.

What is the symbol of Inhibikase Therapeutics Inc?

The ticker symbol of Inhibikase Therapeutics Inc is IKT.

What is the 52-week high of Inhibikase Therapeutics Inc?

The 52-week high of Inhibikase Therapeutics Inc is 2.61.

What is the 52-week low of Inhibikase Therapeutics Inc?

The 52-week low of Inhibikase Therapeutics Inc is 1.40.

What is the market capitalization of Inhibikase Therapeutics Inc?

The market capitalization of Inhibikase Therapeutics Inc is 212.10M.

Is Inhibikase Therapeutics Inc (IKT) currently rated as Buy, Hold, or Sell?

According to analysts, Inhibikase Therapeutics Inc (IKT) has an overall rating of Buy, with a price target of 5.55.

What is the Earnings Per Share (EPS TTM) of Inhibikase Therapeutics Inc (IKT)?

The Earnings Per Share (EPS TTM) of Inhibikase Therapeutics Inc (IKT) is -0.43.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.